Daniel J. Geenen

Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial

Gert Van Assche, William J. Sandborn, Brian G. Feagan et al. · Gut · 2006 · 146 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease

Joseph A. Murray, Ciarán P. Kelly, Peter H.R. Green et al. · Gastroenterology · 2016 · 135 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +9

Endoscopic therapy for benign bile duct strictures

Daniel J. Geenen, Joseph E. Geenen, Walter J. Hogan et al. · Gastrointestinal Endoscopy · 1989 · 96 citations

Medicine, Internal Medicine, Surgery +13

Clinical presentation and short-term outcome of endoscopic therapy of patients with symptomatic incomplete pancreas divisum

Leslie Jacob, Joseph E. Geenen, Marc F. Catalano et al. · Gastrointestinal Endoscopy · 1999 · 55 citations

Medicine, Surgery, Gastroenterology +12

Low Incidence of Aerodigestive Cancers in Patients With Negative Results From Colonoscopies, Regardless of Findings From Multitarget Stool DNA Tests

Barry M. Berger, John B. Kisiel, Thomas F. Imperiale et al. · Clinical Gastroenterology and Hepatology · 2019 · 25 citations · Full text

Medicine, Oncology, Cancer Epidemiology +14